New single-source drug submissions under review

Information on the status of manufacturers' drug submissions that allows industry stakeholders and the public to track the status of drug submissions through the various stages of the review cycle.

Data and Resources

Additional Info

Field Value
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward